Market Overview The CAR-T cell therapy market size was valued at USD 7.31 billion in 2024 and is projected to register a CAGR of 36.8% from 2025 to 2034. CAR-T therapy involves modifying a patient's T-cells to express receptors targeting cancer cells, offering a promising treatment for various hematologic malignancies and, more recently, solid tumors. The market's expansion is fueled by ongoing...